Pharmaceuticals company is investing £400m in UK life sciences and moving scientists to new Cambridge R&D site

The pharma hasn’t yet revealed what kind of job cuts might be involved in the plan, which will help it absorb the coming loss of patents important to its HIV drug franchise.

The move will impact around 1,800 staff currently based in Stevenage.